Metallothionein 2A inhibits NF-κB pathway activation and predicts clinical outcome segregated with TNM stage in gastric cancer patients following radical resection. [electronic resource]
Producer: 20131231Description: 173 p. digitalISSN:- 1479-5876
- Adult
- Aged
- Aged, 80 and over
- Cell Line, Tumor
- Cyclin D1 -- metabolism
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- I-kappa B Proteins -- metabolism
- Immunohistochemistry
- Male
- Metallothionein -- metabolism
- Middle Aged
- NF-KappaB Inhibitor alpha
- NF-kappa B -- metabolism
- Prognosis
- Signal Transduction
- Stomach Neoplasms -- metabolism
- Treatment Outcome
- Up-Regulation
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.